Mandating the coverage of abuse deterrent opioids is a flawed approach and the FDA acknowledges that these products are not abuse proof.
Editor's note · Context
Gillibrand criticizes mandatory coverage of abuse deterrent opioids.
Share
More from Kirsten Gillibrand
As New Yorkers continue to combat the impacts of severe weather and disaster events like the flooding that took place in May, I will continue to work to deliver this critical federal assistance for communities across the five boroughs.
Republicans have failed the American people with a record that has ripped away health care and raised costs on families, and they know voters will hold them accountable in November — which is exactly why they are rewriting the rules in an…
Delaying the implementation of these rules means that students of all ages will continue to face systemic barriers to a quality education.
New York State is the business capital of the world. I am thrilled that American Express is expanding its footprint in New York with a new headquarters on the World Trade Center campus in partnership with the Port Authority.





